scholarly article | Q13442814 |
P50 | author | Coralia Bleotu | Q73988683 |
Adriana Octaviana Dulamea | Q87152218 | ||
P2093 | author name string | Giancarlo Comi | |
Denisa Dragu | |||
Ioana Lupescu | |||
Lucia Moldovan | |||
Mirela-Patricia Sirbu-Boeti | |||
P2860 | cites work | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 |
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study | Q34132522 | ||
Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration | Q34243010 | ||
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | Q34469147 | ||
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis | Q34564111 | ||
Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. | Q34600820 | ||
Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases | Q34646024 | ||
Role of whole bone marrow, whole bone marrow cultured cells, and mesenchymal stem cells in chronic wound healing | Q35552570 | ||
Regenerative and immunomodulatory potential of mesenchymal stem cells | Q36507841 | ||
Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases | Q37891375 | ||
Mesenchymal stromal cells: new directions. | Q38019173 | ||
Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study | Q40271549 | ||
Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice | Q46499204 | ||
Transplantation of mesenchymal stem cells cultured on biomatrix support induces repairing of digestive tract defects, in animal model. | Q47957296 | ||
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis | Q48227850 | ||
Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. | Q48434572 | ||
Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice | Q48497239 | ||
Neuromyelitis optica | Q80833376 | ||
Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells | Q94946139 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neuromyelitis optica | Q611458 |
mesenchymal stem cell | Q1922379 | ||
P304 | page(s) | 1841-1845 | |
P577 | publication date | 2015-11-01 | |
P1433 | published in | Neural Regeneration Research | Q15710164 |
P1476 | title | Autologous mesenchymal stem cells applied on the pressure ulcers had produced a surprising outcome in a severe case of neuromyelitis optica | |
P478 | volume | 10 |
Q57538743 | The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review | cites work | P2860 |
Search more.